[A multi-center clinical trial of Qianlieantong tablets for chronic prostatitis].

Abstract

OBJECTIVE:

To observe the efficacy and safety of Qianlieantong Tablets in the treatment of chronic prostatitis.

METHODS:

A multi-center, self-controlled open clinical trial was conducted. A total of 280 subjects with chronic prostatitis were enrolled and treated by Qianlieantong Tablets, 3 times a day, 5 tablets each time. Before and after 2 and 4 weeks after the administration, NIH-CPSI scores and white blood cell counts in the prostate secretion were recorded.

RESULTS:

Of the 273 subjects evaluated, the rates of excellence, effectiveness and ineffectiveness were 35.2% (n = 96), 47.6% (n = 130) and 17.2% (n = 47), respectively, with a total effectiveness rate of 82.8%. After 4 weeks'medication, the scores of the subjects on NIH-CPSI pain, voiding and quality of life and white blood cell counts in prostate secretion were significantly decreased compared with pre-treatment (P < 0.01). No adverse events or laboratory abnormality related to the medication were observed.

CONCLUSION:

Qianlieantong Tablets has a significant effect on chronic prostatitis with high safety, particularly indicated in chronic prostatitis with pelvic pain.

• Authors: Kai Guo, Ming-Xing Qiu, Song-Liang Cai, Jing Leng, Yin-Fa Han, Guo-Xing Shao, Chuan-Hang Wang, Xiang-An Tu, Luo-Yan Yang, Ge-Ming Chen, Qiang Zhou, Yong Deng, Xiao-Long Wang
• Journal: Zhonghua nan ke xue = National journal of andrology (Zhonghua Nan Ke Xue) Vol. 13 Issue 10 Pg. 950-2 (Oct 2007) ISSN: 1009-3591 [Print] China
• PMID: 17977332 (Publication Type: Clinical Trial, English Abstract, Journal Article, Multicenter Study)

Chemical References

• Drugs, Chinese Herbal
• Tablets
• qianlieantong

Topics

• Adult
• Chronic Disease
• Drug Administration Schedule
• Drugs, Chinese Herbal (administration & dosage, therapeutic use)
• Humans
• Male
• Medicine, Chinese Traditional
• Middle Aged
• Prostatitis (drug therapy)
• Quality of Life
• Tablets
• Treatment Outcome